Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate and Corticosteroids for First-line Treatment of Acute GVHD
NCT03371667Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2018
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Assistance publique - Hôpitaux de Paris. Started Aug 2018; status: completed.
02
Drugs
methotrexate
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT03371667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371667.